Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Oct;85(4):436-480.
doi: 10.1016/j.jinf.2022.06.027. Epub 2022 Jul 1.

Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis

Mingyang Yang  1 , Toni Li  2 , Yushu Wang  3 , Carolyn Tran  4 , Siyi Zhao  5 , Guangyu Ao  6
Affiliations
Meta-Analysis

Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis

Mingyang Yang et al. J Infect. 2022 Oct.
No abstract available

Keywords: COVID-19; Monoclonal antibody; Transplant recipient.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no competing interest.

Figures

Fig 1
Fig. 1
(A) Association between mAbs treatment and mortality (B) Association between mAbs treatment and developing severe COVID-19.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Tang K., Wu X., Luo Y., Wei Z., Feng L., Wu L. Meta-analysis of immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients. J Infect. 2022;84(5):e73–e75. doi: 10.1016/j.jinf.2022.02.016. - DOI - PMC - PubMed
    1. Ahearn A.J., Thin Maw T., Mehta R., et al. A programmatic response, including bamlanivimab or casirivimab-imdevimab administration, reduces hospitalization and death in COVID-19 positive abdominal transplant recipients. Transplantation. 2022;106(2):e153–e157. doi: 10.1097/TP.0000000000003953. - DOI - PubMed
    1. Del Bello A., Marion O., Vellas C., Faguer S., Izopet J., Kamar N. Anti-SARS-CoV-2 monoclonal antibodies in solid-organ transplant patients. Transplantation. 2021;105(10):e146–e147. doi: 10.1097/TP.0000000000003883. - DOI - PMC - PubMed
    1. Chavarot N., Melenotte C., Amrouche L., et al. Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection. Kidney Int. 2022;101(6):1290–1293. doi: 10.1016/j.kint.2022.04.003. - DOI - PMC - PubMed
    1. Gueguen J., Colosio C., Del Bello A., et al. Early administration of anti-SARS-CoV-2 monoclonal antibodies prevents severe COVID-19 in kidney transplant patients. Kidney Int Rep. 2022;7(6):1241–1247. doi: 10.1016/j.ekir.2022.03.020. - DOI - PMC - PubMed

Substances